These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 15006483)

  • 1. Schizophrenia as a disorder of neuroplasticity.
    McCullumsmith RE; Clinton SM; Meador-Woodruff JH
    Int Rev Neurobiol; 2004; 59():19-45. PubMed ID: 15006483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabotropic glutamate receptor protein expression in the prefrontal cortex and striatum in schizophrenia.
    Gupta DS; McCullumsmith RE; Beneyto M; Haroutunian V; Davis KL; Meador-Woodruff JH
    Synapse; 2005 Sep; 57(3):123-31. PubMed ID: 15945063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodevelopment, neuroplasticity, and new genes for schizophrenia.
    Arnold SE; Talbot K; Hahn CG
    Prog Brain Res; 2005; 147():319-45. PubMed ID: 15581715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzazoles as allosteric potentiators of metabotropic glutamate receptor 2 (mGluR2): efficacy in an animal model for schizophrenia.
    Govek SP; Bonnefous C; Hutchinson JH; Kamenecka T; McQuiston J; Pracitto R; Zhao LX; Gardner MF; James JK; Daggett LP; Rowe BA; Schaffhauser H; Bristow LJ; Campbell UC; Rodriguez DE; Vernier JM
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4068-72. PubMed ID: 16005222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The possible involvement of metabotropic glutamate receptors in schizophrenia.
    Krivoy A; Fischel T; Weizman A
    Eur Neuropsychopharmacol; 2008 Jun; 18(6):395-405. PubMed ID: 18063347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamatergic neurotransmission modulators as emerging new drugs for schizophrenia.
    Heresco-Levy U
    Expert Opin Emerg Drugs; 2005 Nov; 10(4):827-44. PubMed ID: 16262565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamate receptor plasticity at excitatory synapses in the brain.
    Genoux D; Montgomery JM
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1058-63. PubMed ID: 17714094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early brain development disruption from NMDA receptor hypofunction: relevance to schizophrenia.
    du Bois TM; Huang XF
    Brain Res Rev; 2007 Feb; 53(2):260-70. PubMed ID: 17014910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Widespread brain distribution of the Drosophila metabotropic glutamate receptor.
    Devaud JM; Clouet-Redt C; Bockaert J; Grau Y; Parmentier ML
    Neuroreport; 2008 Feb; 19(3):367-71. PubMed ID: 18303583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the mGlu8 receptor as a putative therapeutic target in schizophrenia.
    Robbins MJ; Starr KR; Honey A; Soffin EM; Rourke C; Jones GA; Kelly FM; Strum J; Melarange RA; Harris AJ; Rocheville M; Rupniak T; Murdock PR; Jones DN; Kew JN; Maycox PR
    Brain Res; 2007 Jun; 1152():215-27. PubMed ID: 17434465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic drug actions on gene modulation and signaling mechanisms.
    Molteni R; Calabrese F; Racagni G; Fumagalli F; Riva MA
    Pharmacol Ther; 2009 Oct; 124(1):74-85. PubMed ID: 19540875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasticity-dependent changes in metabotropic glutamate receptor expression at excitatory hippocampal synapses.
    Cheyne JE; Montgomery JM
    Mol Cell Neurosci; 2008 Mar; 37(3):432-9. PubMed ID: 18191411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synaptic pathology of schizophrenia: is aberrant neurodevelopment and plasticity to blame?
    Eastwood SL
    Int Rev Neurobiol; 2004; 59():47-72. PubMed ID: 15006484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabotropic glutamate receptors in the tripartite synapse as a target for new psychotropic drugs.
    WieroĊ„ska JM; Pilc A
    Neurochem Int; 2009; 55(1-3):85-97. PubMed ID: 19428811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
    Javitt DC
    Int Rev Neurobiol; 2007; 78():69-108. PubMed ID: 17349858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Can concepts of neurodevelopment and neuroplasticity explain post-traumatic psychoses?].
    Thomas G; Genest P; Walter M; Cozic JY
    Neurochirurgie; 2009 Feb; 55(1):36-9. PubMed ID: 19059615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain-derived neurotrophic factor in schizophrenia and its relation with dopamine.
    Guillin O; Demily C; Thibaut F
    Int Rev Neurobiol; 2007; 78():377-95. PubMed ID: 17349867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translational and developmental perspective on N-methyl-D-aspartate synaptic deficits in schizophrenia.
    MacDonald AW; Chafee MV
    Dev Psychopathol; 2006; 18(3):853-76. PubMed ID: 17152404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dopamine system and the pathophysiology of schizophrenia: a basic science perspective.
    Goto Y; Grace AA
    Int Rev Neurobiol; 2007; 78():41-68. PubMed ID: 17349857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondria, synaptic plasticity, and schizophrenia.
    Ben-Shachar D; Laifenfeld D
    Int Rev Neurobiol; 2004; 59():273-96. PubMed ID: 15006492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.